Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Phase 1b study of galunisertib and ramucirumab in patients with advanced hepatocellular carcinoma

Published:2021-04-02 Issue:9 Volume:10 Page:3059-3067
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Harding James J.¹²^ORCID,Do Richard K.¹²,Yaqubie Amin¹,Cleverly Ann³,Zhao Yumin³,Gueorguieva Ivelina³,Lahn Michael³,Benhadji Karim A.³,Kelley Robin K.⁴,Abou‐Alfa Ghassan K.¹²^ORCID

Affiliation:

1. Memorial Sloan Kettering Cancer Center New York NY USA

2. Weill Cornell Medical College New York NY USA

3. Elli Lilly and Company Indianapolis IN USA

4. Helen Diller Cancer Center University of California San Francisco San Francisco CA USA

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3880

Reference34 articles.

1. Treating advanced hepatocellular carcinoma: How to get out of first gear

2. Sorafenib in Advanced Hepatocellular Carcinoma

3. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

4. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial

5. Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. m⁶A‐Dependent ITIH1 Regulated by TGF‐β Acts as a Target for Hepatocellular Carcinoma Progression;Advanced Science;2024-09-05

2. Predictive biomarkers for response to TGF- β inhibition in resensitizing chemo(radiated) esophageal adenocarcinoma;Pharmacological Research;2024-09

3. Galunisertib promotes bevacizumab-induced vascular normalization in nasopharyngeal carcinoma: Multi-parameter MRI evaluation;Molecular Therapy: Oncology;2024-09

4. Targeting cytokine and chemokine signaling pathways for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-22

5. Hepatocellular Carcinoma: Current Drug Therapeutic Status, Advances and Challenges;Cancers;2024-04-20